- Dianne L. Clarke, Ph.D.
- Wesley L. Geminn, PharmD, BCPP
- Judith A. Martin, M.D.
- Charisse Evonne Peoples, Ph.D.
- Eva Petoskey, M.S.
- A. Kenison Roy III, M.D., DFASAM, DLFAPA
- Kenneth Stoller, M.D.
EX OFFICIO MEMBERS
- The Honorable Xavier Becerra, Acting Secretary, U.S. Department of Health and Human Services
- Miriam E. Delphin-Rittmon, Ph.D., Assistant Secretary for Mental Health and Substance Use, Substance Abuse and Mental Health Services Administration
- David J. Smith, M.D., Acting Assistant Secretary of Defense for Health Affairs, U.S. Department of Defense
- George F. Koob, Ph.D., Director, National Institute on Alcohol Abuse and Alcoholism
- Nora D. Volkow, M.D., National Institute on Drug Abuse
- The Honorable Denis Richard McDonough, Secretary, Veterans Affairs
Dianne L. Clarke, Ph.D.
Dianne Clarke, Ph.D. is the Chief Executive Officer of Operation PAR, Inc. and has more than 40 years of experience in the field of substance use disorder treatment As one of the original individuals to be certified as an Addiction Professional in Florida, Dr. Clarke has experience in all phases of substance use treatment for both adolescents and adults including; detoxification , residential treatment and all levels of outpatient treatment to include medication assisted treatment. Dr. Clarke is also one of the first individuals certified by the Florida Certification Board as a Telehealth Practitioner. Dr. Clarke is responsible for the operational activities for comprehensive behavioral health services for more than 50 programs in seven counties in Florida. Dr. Clarke is an Executive Board Member of the Florida Behavioral Health Association, Co-Chair of the Pinellas County Opiate Task Force, and Executive Board Member of the Florida Juvenile Justice Association.
Wesley L. Geminn, PharmD, BCPP
Wesley L. Geminn, PharmD, BCPP, is the Chief Pharmacist and SOTA Authority for the Tennessee Department of Mental Health and Substance Abuse Services' Division of Clinical Leadership. Dr. Geminn graduated from the University of Tennessee College of Pharmacy and completed a post-graduate residency in managed care and psychiatry with the Tennessee Department of Mental Health and Substance Abuse Services. He is currently board-certified in psychiatry by the Board of Pharmaceutical Specialties.
Judith A. Martin, M.D.
Dr. Judith Martin is an addiction specialist who has worked with opioid-addicted patients and their families for over twenty years. She has provided training about methadone and buprenorphine treatment for addiction to physicians and clinic staff from many states. She recently retired as Medical Director for Substance Use Services at San Francisco's Community Behavioral Health Services. Her previous position was Medical Director at BAART Turk Street Clinic in San Francisco's Tenderloin district. Dr. Martin has been President of the California Society of Addiction Medicine (CSAM) and has been on the Executive Council and the Committee for the Treatment of Opiate Dependence of that organization. She has also participated in the National Institute of Drug Abuse (NIDA)'s Clinical Trials Network (CTN) on multi-site research studies of treatment of opioid and cocaine use disorders.
Charisse Evonne Peoples, Ph.D.
Charisse Evonne Peoples, Ph.D., is a licensed psychologist with experience in providing psychological evaluation and therapeutic services for adults and children of all ages. She was pivotal in implementing evidence-based practices of core correctional intervention strategies, including Motivational Interviewing and Cognitive Behavioral Intervention techniques, to reduce recidivism and relapse rates for those in the criminal justice system in Washington, DC. Dr. Peoples has expertise in both Criminal Justice and African American Minority Population.
Eva Petoskey, M.S.
Ms. Eva Petoskey has over 45 years of experience working with tribal communities throughout the Great Lakes region and nationwide on wellness, education, evaluation, and culture issues. Since July 2022, she has been the Manager of Tribal Training and Technical for BLH Technologies, Inc. Before her current position, from 1993 to 2022, she provided leadership for initiatives supporting healing from addictions and inter-generational trauma thru the Inter-Tribal Council of Michigan, Inc. where she served as the Behavioral Health Division Director until her retirement in 2022. Ms. Petoskey has created innovative culturally based evaluation approaches and instruments using storytelling and digital technology. She is a founding member of the First American Prevention Center. This tribally-based organization played a leadership role nationwide in developing culturally-based curricula and training services for Indian Tribes and organizations. She is the author of the Red Cliff Wellness Curriculum, a culturally based substance abuse prevention and community empowerment model used in over 130 schools and communities in the U.S. and Canada. She has worked as a Senior Planner for the Minnesota Department of Human Services, Chemical Dependency Division. She was responsible for monitoring and evaluating a State grant program that made federal block grant dollars available to Minnesota Tribes for substance abuse services. She has also worked at the Minnesota Indian Women’s Resource Center, the University of Minnesota, and the Great Lakes Inter-Tribal Council of Wisconsin.
Ms. Petoskey is co-author of articles related to engaging communities in change: Prevention Through Empowerment in a Native American Community, Drugs and Society, Vol. 12, No 1/2, 1998, pp. 147-162; Strategies and Tactics of Program Evaluation: Implementation Issues, Center for Substance Abuse Prevention, 1999. She has authored numerous program and evaluation reports. Ms. Petoskey is an enrolled member of the Grand Traverse Band of Ottawa and Chippewa Indians. She has served on the Tribal Council of the Grand Traverse Band for six years and four years as the Vice-Chairperson She has a long-standing commitment to living her life based on Anishnaabek values. She has been on a healing journey since 1979 – over 45 years in recovery.
A. Kenison Roy III, M.D., DFASAM, DLFAPA
A. Kenison Roy, III, M.D. (Ken) is Associate Professor of Psychiatry and Addiction Medicine at Tulane School of Medicine, Director of the Division of Addiction Medicine within the Department of Psychiatry, and Program Director of the Addiction Medicine Fellowship. He is a Distinguished Life Fellow of the American Psychiatric Association and a Distinguished Fellow of the American Society of Addiction Medicine. He is certified by the American Board of Psychiatry and Neurology, The American Board of Preventive Medicine in Addiction Medicine and the American Board of Addiction Medicine. He is a member of the American Society of Addiction Medicine, the American Academy of Addiction Psychiatry, The American College of Psychiatrists, the American Medical Association, the Louisiana State Medical Society and the Louisiana Psychiatric Medical Association (LPMA) and is a Past President of LPMA. He has long held leadership positions in the American Society of Addiction Medicine (ASAM) and was most recently a member of the Board of Directors representing Region VII.
Kenneth Stoller, M.D.
Dr. Stoller is an Associate Professor of Psychiatry and Behavioral Sciences and Director of the Johns Hopkins Broadway Center for Addiction (Johns Hopkins). His area of expertise is treatment and clinical research involving substance use problems and, in particular, the use of methadone and buprenorphine. His research interests have centered on cost issues as they relate to drug abuse and treatment, methods to enhance treatment adherence and retention, and co-occurring psychiatric, medical, pain, and substance use disorders. Published manuscripts and book chapters focus on the use of adaptive stepped care, treatment incentives, and integrated treatment of co-occurring disorders in a single setting. Through his work at Johns Hopkins Health Care, he has developed a related focus on fostering policies and initiatives applied in managed care settings to improve health outcomes and control costs, such as increasing the identification and treatment of substance use disorder and coordinating treatment of general somatic, mental health, and substance use disorders. More recently, since assuming the role of Director of the outpatient addiction treatment program for Johns Hopkins—particularly since his involvement with the American Association for the Treatment of Opioid Dependence, and as the representative on the Board of Directors for Maryland—he has refocused his academic work on the pursuit of increasing access to, and quality of, medication-assisted therapies in Baltimore, Maryland, and nationally. This work has received intense attention over the past two years, especially as it relates to coordinated care using opioid treatment programs as hubs of expertise and coordinating with community physicians prescribing medications for opioid use disorder. Dr. Stoller created and implemented the first known buprenorphine hub and spoke collaborative care model in the nation, and this is the subject of numerous presentations, webinars, and white papers.